Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Primary Healthcare Services01:30

Primary Healthcare Services

1.9K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.9K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

14.1K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
14.1K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

439
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
439
Healthcare Agencies II01:17

Healthcare Agencies II

1000
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
1000
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A reappraisal of APOE genetic effects on Alzheimer's disease risk in the Japanese population: a meta-analysis.

Molecular neurodegeneration·2026
Same author

CCN1/Cyr61 associates with β-amyloid levels in human cerebrospinal fluids.

iScience·2026
Same author

Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations.

Frontiers in molecular neuroscience·2026
Same author

Hypertrophic Cardiomyopathy and Sudden Cardiac Arrest Associated with a PSEN1 Variant: A Case Report.

Internal medicine (Tokyo, Japan)·2026
Same author

Clinical course after cardiac resynchronization therapy in transthyretin amyloid cardiomyopathy receiving disease-modifying therapy.

Heart and vessels·2026
Same author

Clinical Practice and Diagnostic Trends in Hereditary Transthyretin Amyloidosis: A 25-Year Observational Study.

Medicina (Kaunas, Lithuania)·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 8, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
10:57

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children

Published on: August 22, 2012

24.2K

Salud Pública

Kensaku Kasuga1, Soichiro Shimizu2, Noriyuki Kimura3

  • 1Niigata University, Niigata, Niigata, Japan.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 23, 2025
PubMed
Resumen
Este resumen es generado por máquina.

El viaje diagnóstico de la enfermedad de Alzheimer (EA) en Japón dura aproximadamente 2,2 años. El retraso más largo ocurre antes de la primera visita médica, lo que resalta la necesidad de una mayor concienciación y consulta rápida para un diagnóstico y tratamiento tempranos de la EA.

Palabras clave:
enfermedad de AlzheimerdiagnósticoretrasoJapónatención médicaconcienciación pública

Más Videos Relacionados

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.6K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Videos de Experimentos Relacionados

Last Updated: Jan 8, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
10:57

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children

Published on: August 22, 2012

24.2K
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.6K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Área de la Ciencia:

  • Neurología
  • Geriatría
  • Salud Pública

Sus antecedentes:

  • El diagnóstico temprano de la enfermedad de Alzheimer (EA) es crucial para un tratamiento eficaz.
  • El viaje diagnóstico de los pacientes con EA en Japón sigue siendo poco conocido.
  • Este estudio investiga el cronograma y los cuellos de botella en el diagnóstico de la EA en Japón.

Objetivo del estudio:

  • Investigar el tiempo desde el inicio de los síntomas hasta el diagnóstico en pacientes japoneses con EA.
  • Identificar el principal cuello de botella en la vía de diagnóstico de la enfermedad de Alzheimer.
  • Analizar los retrasos diagnósticos tanto en la EA de inicio temprano (EOAD) como en la de inicio tardío (LOAD).

Principales métodos:

  • Estudio observacional retrospectivo de 138 pacientes diagnosticados con probable demencia por EA o MCI debido a EA en Japón (2011-2023).
  • Sujetos de 18 a 79 años, clasificados en EOAD (<65 años) y LOAD (≥65 años), emparejados 1:1.
  • Datos extraídos de historias clínicas electrónicas, centrándose en los intervalos de tiempo desde el inicio de los síntomas hasta el diagnóstico.

Principales resultados:

  • El tiempo promedio desde el inicio de los síntomas hasta el diagnóstico de EA fue de 121,8 ± 88,9 semanas (aproximadamente 2,2 años).
  • El retraso más largo se observó entre el inicio de los síntomas y la primera visita médica (77,0 ± 74,4 semanas).
  • Los retrasos posteriores incluyeron: primera visita a derivación especializada (34,9 ± 49,2 semanas) y derivación especializada a diagnóstico (10,5 ± 18,8 semanas).

Conclusiones:

  • La duración total del diagnóstico de la enfermedad de Alzheimer en Japón es de aproximadamente 2,2 años.
  • Minimizar el tiempo desde el inicio de los síntomas hasta el contacto médico inicial es clave para acortar el período de diagnóstico general.
  • Aumentar la concienciación pública y del paciente sobre los síntomas de la EA y la importancia de la consulta temprana es vital para un tratamiento oportuno.